Search
for
Sort by
Research 901–930 of 1000+
- Finasteride Inhibits Melanogenesis throughthe Regulation of Melanocortin 1 Receptorin Melanocytes
- Clinical Evaluation and Therapeutic Outcome in Hirsutism
- Clinical Snippets
- MALE PSEUDOHERMAPHRODITISM DUE TO 17β-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY: STUDIES ON THE NATURAL HISTORY OF THE DEFECT AND EFFECT OF ANDROGENS ON GENDER ROLE
- The mutational analysis of mitochondrial DNA in maternal inheritance of polycystic ovarian syndrome
- Policistisko olnīcu sindroms pusaudzēm – starppaaudžu, ģenētiskie, dzīves kvalitātes un negausīgas ēšanas aspekti. Promocijas darbs
- Do Pleiotropic Effects of Spironolactone in Women with PCOS make it More Than an Anti-Androgen? Evidence from a Systematic Review and Meta-Analysis
- Effects of antiandrogen therapy of cyproteron acetate on androgen effects on the skin including androgenetic alopecia in menopausal women – case report: 10 years follow up –
- Faculty Opinions recommendation of Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
- Influence of finasteride treatment on metabolic profile of men with androgenetic alopecia
- Is there male androgenetic alopecia the sign of male equivalent of polycystic ovary syndrome or metabolic syndrome
- Polycystic ovary syndrome
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- Polycystic ovary syndrome
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin
- Molecular basis of androgen insensitivity
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Polycystic ovary syndrome
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Current Guidelines for Diagnosing PCOS
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Adult female acne: a guide to clinical practice
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- SEXUAL DIMORPHISM IN MAMMALS